Silverback Therapeutics shares owned by K2 Principal Fund
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by K2 Principal Fund
from 13F filings
Historical chart of K2 Principal Fund investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by K2 Principal Fund consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by K2 Principal Fund
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.3M | 226k | 14.50 |
| 2024-06-30 | $22M | 2.6M | 8.51 |
| 2024-03-31 | $24M | 2.4M | 10.22 |
| 2023-12-31 | $20M | 3.7M | 5.48 |
| 2023-09-30 | $12M | 3.2M | 3.78 |
| 2023-06-30 | $15M | 2.2M | 6.70 |
| 2023-03-31 | $18M | 2.8M | 6.51 |
| 2022-12-31 | $25M | 2.9M | 8.53 |
| 2022-09-30 | $17M | 3.2M | 5.20 |
| 2022-06-30 | $6.5M | 1.5M | 4.24 |